POVETACICEPT
UNII EN2U82XV65

Substance Identification & Data

This profile provides standardized clinical and technical data for Povetacicept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EN2U82XV65.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2490217-42-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

EN2U82XV65

CAS Registry Number

2490217-42-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

POVETACICEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190436

National Cancer Institute reference terminology for clinical and research data.

INN ID

12264

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-215

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Povetacicept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

POVETACICEPT

Common Names & Synonyms

68-110-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF13B (77-GLUTAMIC ACID,78-TYROSINE,102-ASPARTIC ACID) (HUMAN) FUSION WITH PEPTIDE LINKER (GSGGGGS) FUSION WITH IMMUNOGLOBULIN G1 (5-SERINE,19-ALANINE,20-GLUTAMIC ACID,22-ALANINE,DE-C-TERMINAL-LYSINE) (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), DIMER

ALPN-303 (DUAL BAFF/APRIL FC FUSION ANTAGONIST)

HUMAN TACI (TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 13B, TNFRSF13B, CD267) RECEPTOR DOMAIN 68-110 FRAGMENT (K77>E10, F78>Y11, Y102>D35)-MUTANT (1-43), FUSED VIA A GSG4S PEPTIDE LINKER (44-50) WITH 232 C-TERMINAL RESIDUES OF A MUTATED HUMAN IMMUNOGLOBULIN G1 GAMMA1 HEAVY CHAIN (51-281) (HOMO SAPIENS IGHG1*01, HINGE C55>S (51-65), CH2 L69>A, L70>E, G72>A (66-175), CH3 (176-280), CHS K282>DEL (281)), (61-61':64-64')-BISDISULFIDE DIMER, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1 GS-, GLYCOFORM ALFA

POVETACICEPT [INN]

POVETACICEPT [USAN]